ROBERT KETCHUM: Open Payments
NPI 1578702197 · PORTSMOUTH, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,232 in 43 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $185 · 2025 $1,232
Food & beverage: $1,232
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $288 |
| QOL Medical, LLC | 5 | $182 |
| Phathom Pharmaceuticals, Inc. | 2 | $166 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $132 |
| Novo Nordisk Inc | 2 | $128 |
| Gilead Sciences, Inc. | 3 | $64 |
| GENZYME CORPORATION | 1 | $62 |
| Ardelyx, Inc. | 1 | $34 |
| Madrigal Pharmaceuticals | 1 | $31 |
| Intercept Pharmaceuticals, Inc. | 1 | $29 |
Products named: Sucraid, VOQUEZNA, ENTYVIO, CREON, Wegovy, MAVYRET, DUPIXENT, RINVOQ.
Industry payments across NH — which companies pay providers there.
